Gynecologic Cancer
Rutgers Cancer Institute of New Jersey names gynecologic oncology chief
James K. Aikins Jr., MD, FACOG, FACS, has been appointed chief of gynecologic oncology at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital.
FDA grants fast track designation to TH1902 for sortilin-expressing cancers
The FDA granted fast track designation to TH1902 for treatment of certain patients with sortilin-expressing cancers, according to the agent’s manufacturer.
Breast cancer supersedes lung as most common cancer diagnosis
Female breast cancer has become the most common cancer worldwide, with an estimated 2.3 million new cases diagnosed last year alone, according to the Global Cancer Statistics 2020 report.
Cedars-Sinai appoints gynecologic oncology division director
Rutgers Cancer Institute of New Jersey appoints immunotherapy chief
Christian Hinrichs, MD, has been appointed chief of the section of cancer immunotherapy at Rutgers Cancer Institute of New Jersey.
Older women with ovarian cancer may benefit from more aggressive treatment
Upfront cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy may be a viable treatment for certain older women with ovarian cancer, according to results of a study published in Annals of Surgical Oncology.
Roswell Park Comprehensive Cancer Center announces appointments, promotions
Roswell Park Comprehensive Cancer Center announced the hiring or promotion of several people across clinical, administrative and research departments.
FDA grants fast track designation to zenocutuzumab for neuregulin 1 fusion cancers
The FDA granted fast track designation to zenocutuzumab for treatment of patients with metastatic solid tumors that harbor neuregulin 1 fusion cancers that progressed on standard therapy.
City of Hope vice chair invited to join fellowship class
Lorna Rodriguez-Rodriguez, MD, PhD, has been invited to join The Carol Emmott Fellowship Class of 2021.
FDA updates safety guidance, labeling requirements for power morcellators
The FDA today issued a safety communication for patients and their health care providers that stresses the importance of shared decision-making regarding use of laparoscopic power morcellators during gynecologic surgeries.